Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neurodyn Life Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11193
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurodyn Life Sciences Inc (Neurodyn Life Sciences), formerly Neurodyn Inc is a provider of validation and development of bioactives for neuroprotection and early treatment of neurological diseases. The company’s products include neuroprotectant, memogain, progranulin, and nerve pain treatment. Its Neuroprotectant, is a saponin based bioactive that is used for protection of early stage Parkinson’s disease, Progranulin is a bioactive used for the neuroprotection and treatment of Parkinson’s disease, and nerve pain treatment is a lipophilic compound that acts as an antagonists for sodium and TRP ion channels. Neurodyn Life Sciences develops bioactives for neuroprotection and for treating neurological diseases. The company also provides contract research services for medicinal chemistry. It caters to pharmaceutical and consumer health players. Neurodyn Life Sciences is headquartered in Charlottetown, Canada.

Neurodyn Life Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Neurodyn Acquires Memogain Related Assets From Galantos Pharma 10
Venture Financing 11
Neurodyn Cognition Raises USD0.2 Million in Venture Financing 11
Neurodyn Cognition Raises USD0.4 Million in Venture Financing 12
Neurodyn Raises USD0.4 Million Financing 13
Neurodyn Life Sciences Raises Funds Through Venture Financing 14
Neurodyn Life Sciences Raises USD0.6 Million in Venture Financing 15
Neurodyn Life Sciences Raises USD0.3 Million in Venture Financing 16
Neurodyn Raises US$1.5 Million In Series A Financing 17
Neurodyn Raises US$0.13 Million In Venture Financing 18
Equity Offering 19
Neurodyn Raises USD0.8 Million in Private Placement of Shares 19
Neurodyn Life Sciences Inc – Key Competitors 20
Neurodyn Life Sciences Inc – Key Employees 21
Neurodyn Life Sciences Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurodyn Acquires Memogain Related Assets From Galantos Pharma 10
Neurodyn Cognition Raises USD0.2 Million in Venture Financing 11
Neurodyn Cognition Raises USD0.4 Million in Venture Financing 12
Neurodyn Raises USD0.4 Million Financing 13
Neurodyn Life Sciences Raises Funds Through Venture Financing 14
Neurodyn Life Sciences Raises USD0.6 Million in Venture Financing 15
Neurodyn Life Sciences Raises USD0.3 Million in Venture Financing 16
Neurodyn Raises US$1.5 Million In Series A Financing 17
Neurodyn Raises US$0.13 Million In Venture Financing 18
Neurodyn Raises USD0.8 Million in Private Placement of Shares 19
Neurodyn Life Sciences Inc, Key Competitors 20
Neurodyn Life Sciences Inc, Key Employees 21
Neurodyn Life Sciences Inc, Subsidiaries 22

List of Figures
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Smiths Medical-医療機器分野:企業M&A・提携分析
    Summary Smiths Medical, a division of Smiths Group Plc, is a clinically-focused company, which manufactures medical devices used in various therapeutic, diagnostic and surgical procedures with focus on vital care, safety devices and medication delivery areas. The company’s product line consists of a …
  • Nobel Biocare Services AG:企業の製品パイプライン分析
    Summary Nobel Biocare Services AG (Nobel Biocare), a subsidiary of Danaher Corporation, is a provider of implant-based dental restorations. The company offers various solutions, including dental implant systems; high-precision individualized prosthetics; CAD/CAM systems; diagnostics and treatment pl …
  • Assertio Therapeutics Inc (DEPO):製薬・医療:M&Aディール及び事業提携情報
    Summary Assertio Therapeutics Inc (Assertio), formerly Depomed Inc, is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of the central nervous system. Its product portfolio comprises drugs for the treatment of postherpetic neuralg …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Idorsia Pharmaceutical Ltd (IDIA):製薬・医療:M&Aディール及び事業提携情報
    Summary Idorsia Pharmaceutical Ltd (Idorsia) is a manufacturer and developer of medicine that discovers, develops various therapies. The company provides pipeline portfolio such as investigational candidates targeted at the treatment of resistant hypertension, chronic insomnia, vasospasm, and system …
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, perinatology, urology and electrosurgery, respiratory and OEM products. Its blood pressure monitor …
  • NH Foods Ltd.:企業の戦略・SWOT・財務情報
    NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • NIKE Inc:企業のM&A・事業提携・投資動向
    NIKE Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIKE Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • SPAGO Nanomedical AB-医療機器分野:企業M&A・提携分析
    Summary Spago Nanomedical AB (SPAGO Nanomedical), formerly SPAGO Imaging AB is a drug company that develops proprietary magnetic resonance imaging contrast agent, and the novel therapeutic project tumorad for cancer selective radionuclide treatment. The company concentrates on research and developme …
  • Northrop Grumman Aerospace Systems:企業の戦略・SWOT・財務情報
    Northrop Grumman Aerospace Systems - Strategy, SWOT and Corporate Finance Report Summary Northrop Grumman Aerospace Systems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Advanced Materials Enterprises Co Ltd:企業の製品パイプライン分析2018
    Summary Advanced Materials Enterprises Co Ltd (AME) is a laboratory equipment supplier. The company manufactures group of high precision mechanical components. It offers laboratory and professional equipment, consumer and lifestyle products, industrial heating system, and healthcare products. AME’s …
  • PharmAust Ltd (PAA)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAust Ltd (PharmAust) is a drug discovery and development company which provides human and veterinary proprietary medicines to treat different types of cancers. The company provides specialized medicinal and synthetic chemistry services. It specializes in bio defense and laboratory suppo …
  • Eurofins MWG Operon LLC-製薬・医療分野:企業M&A・提携分析
    Summary Eurofins MWG Operon LLC (Eurofins) is a biotechnology company that provides DNA sequencing, DNA synthesis and bioinformatic services. The company’s products include DNA tube oligos, large scale synthesis, large scale synthesis, oligo modifications, oligo modifications, real-time QPCR probes, …
  • CSA Medical Inc-医療機器分野:企業M&A・提携分析
    Summary CSA Medical Inc (CSA Medical) is a medical device company that offers cryotherapy devices. The company provides spray cryotherapy medical device solutions to improve patient outcomes, simplify procedures, and reduce the cost of healthcare. Its truFreeze system delivers cold liquid nitrogen s …
  • Genisphere LLC-医療機器分野:企業M&A・提携分析
    Summary Genisphere LLC (Genisphere) is a nanotechnology company which provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapuetics. It develops pipeline produc …
  • Tokyo Electric Power Company Holdings Incorporated (9501)-石油・ガス分野:企業M&A・提携分析
    Summary Tokyo Electric Power Company Holdings, Incorporated (TEPCO), formerly Tokyo Electric Power Company, Incorporated, is an integrated energy company. The company generates, transmits, distributes and sells electricity through its subsidiaries. It generates power from various sources such as the …
  • Arizona State University-製薬・医療分野:企業M&A・提携分析
    Summary Arizona State University (ASU) is an educational and research university that provides entrepreneurship solutions. The university’s services include academic services, knowledge enterprise development, institutes and initiative consulting, industry engagement, entrepreneurship, support and c …
  • Pear Therapeutics Inc:企業の製品パイプライン分析2018
    Summary Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive …
  • AusTex Oil Ltd:企業の戦略的SWOT分析
    AusTex Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Toyo Suisan Kaisha, Ltd. (2875):企業の財務・戦略的SWOT分析
    Toyo Suisan Kaisha, Ltd. (2875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆